Alexander Perkelvald - Endocrinology

Doctor Profile

Affiliations: Columbia Affiliated Physicians



Expertise:

Thyroid Disease

Thyroid Nodules

Thyroid Cancer

Goiter

Hyperthyroidism

Hypothyroidism

Parathyroid Disease

Hyperparathyroidism

Cushing's Syndrome

Type 1 Diabetes

Type 2 Diabetes

Insulin pumps

Continuous Glucose Meters – CGM (Dexcom, Libre, Medtronic)

Cholesterol (Lipid) disorders

Primary Location:

1720 E 14th St Ste M2,

Brooklyn, NY 11229

Phone: 718 368 3333



Insurances:

Aetna,

Cigna,

Blue Cross (commercial plans),

Blue Cross (Essential plan),

Blue Cross HealthPlus

HIP (all plans),

UnitedHealthCare-UHC (Out of Network only),

Oxford

1199

HealthFirst

Please also feel free to call as our participation with insurance plans occasionally changes.


Education:

After earning his medical degree from Ross University School of Medicine in Roseau, Dr. Perkelvald completed his residency and fellowships in endocrinology and metabolism at SUNY HSCB. Dr Perkelvald is accredited in thyroid ultrasound and fine needle aspiration biopsy by the American Association of Clinical Endocrinologists.

About:

Dr. Perkelvald is an Endocrinologist, in private practice in Brooklyn, New York. After earning his medical degree from Ross University School of Medicine in Roseau, he completed his residency and fellowship in Endocrinology and metabolism at the State University of New York (SUNY)Health and Science Center in Brooklyn (HSCB).

He is also accredited in thyroid ultrasound and fine needle aspiration biopsy by the American Association of Clinical Endocrinologists. He has coauthored several publications, including a heart protection study focusing on patients with diabetes, and is participating in ongoing industry-funded research projects that examine the treatment of patients with type 2 Diabetes Mellitus.



Publications:

Ogrin C, Perkelvald A, Winer N. Heart Protection Study: a focus on diabetic patients. CurrDiab Rep. 2004 4:185-6.


Winer N, Folker A, Murphy JA, Hung E, Bard M, Perkelvald A, Sowers, JR, Bakris GL. Effect of Fixed-Dose ACE Inhibitor/CCB Combination Therapy vs ACE Inhibitor Monotherapy on Arterial Compliance in Hypertensive Patients With Type 2 Diabetes. Preventive Cardiology. 2005 Spring;8(2):87-92.


Tiewala M, Perkelvald A, Banerji MA, Ogrin C. Reducing mortality in critically ill patients. CurrDiab Rep. 2004 Jun;4(3):210-2.